The company\u2019s large U.S. trial found an efficacy rate of about 90 percent. But at this point, the nation is awash in other shots.<\/p>\n
https:\/\/www.nytimes.com\/2021\/06\/14\/health\/covid-vaccine-novavax.html?action=click&module=Spotlight&pgtype=Homepage<\/a><\/p>\n AND<\/p>\n From the WSJ –><\/p>\n https:\/\/www.wsj.com\/articles\/novavax-covid-19-vaccine-is-90-effective-in-key-study-11623664800?mod=djemalertNEWS<\/a><\/p>\n “The vaccine also contains an adjuvant, a substance designed to enhance immune responses. Novavax\u2019s adjuvant is derived from the bark of an evergreen tree native to Chile.<\/p>\n This approach of combining a protein with an adjuvant is similar to that of vaccines against other diseases, including\u00a0GlaxoSmithKline<\/a>\u00a0GSK\u00a00.20%\u00a0<\/a>PLC\u2019s shingles vaccine, Shingrix.<\/p>\n It is a different mechanism<\/a>\u00a0from the Pfizer-BioNTech and Moderna Covid-19 vaccines, which use gene-based technologies, and those from Johnson & Johnson and\u00a0AstraZeneca<\/a>,<\/span>\u00a0AZN\u00a00.14%\u00a0<\/a>which use viral-vector technology.”<\/p>\n AND<\/p>\n NOVOVAX CORP………\u00a0https:\/\/www.novavax.com\/our-pipeline#nvx-cov2373<\/a><\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" The company\u2019s large U.S. trial found an efficacy rate of about 90 percent. But at this point, the nation is awash in other shots. https:\/\/www.nytimes.com\/2021\/06\/14\/health\/covid-vaccine-novavax.html?action=click&module=Spotlight&pgtype=Homepage AND From the WSJ –> Novavax Covid-19 Vaccine Is 90% Effective, Including Against Variants, New … Continue reading Novavax Covid-19 Vaccine Is 90% Effective, Including Against Variants, New Study Shows<\/h3>\n
Authorization of the two-dose vaccine is months away, however, as Novavax readies manufacturing<\/h3>\n